A biophysical investigation into the binding interactions of novel anti-cancer inhibitors of atypical protein kinase C (aPKCs)

被引：0
|
作者：
Noor, Radwan Ebna
Smalley, Tracess B.
Acevedo-Duncan, Mildred
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3844
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3844
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation
    Radwan, Awwad A.
    Alanazi, Fars
    Al-Dhfyan, Abdullah
    PLOS ONE, 2024, 19 (04):
  • [42] Anti-cancer synergy of dichloroacetate and EGFR tyrosine kinase inhibitors in NSCLC cell lines
    Yang, Zheng
    Tam, Kin Y.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 789 : 458 - 467
  • [43] ANTI-CANCER TYROSINE KINASE INHIBITORS INCREASE OXIDATIVE STRESS IN PRIMARY CARDIAC FIBROBLASTS
    McMullen, C. J.
    McCluskey, C.
    Kim, S. J.
    Laovitthayanggoon, S.
    MacDonald, M.
    Safar, M.
    Wood, R.
    Cunningham, M. R.
    Currie, S.
    HEART, 2018, 104 : A9 - A9
  • [44] PKCU IS A NOVEL, ATYPICAL MEMBER OF THE PROTEIN-KINASE-C FAMILY
    JOHANNES, FJ
    PRESTLE, J
    EIS, S
    OBERHAGEMANN, P
    PFIZENMAIER, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (08) : 6140 - 6148
  • [45] Synthetic cyclin dependent kinase inhibitors -: New generation of potent anti-cancer drugs
    Hajdúch, M
    Havlièek, L
    Vesley, J
    Novotny, R
    Mihál, V
    Strnad, M
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA III, 1999, 457 : 341 - 353
  • [46] Combination of multifunctional ursolic acid with kinase inhibitors for anti-cancer drug carrier vesicles
    Lorincz, A.
    Mihaly, J.
    Wacha, A.
    Nemeth, Cs.
    Besztercei, B.
    Gyulavari, P.
    Varga, Z.
    Petak, I.
    Bota, A.
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2021, 131
  • [47] Expert opinion on thyroid complications of new anti-cancer therapies: Tyrosine kinase inhibitors
    Drui, Delphine
    Illouz, Frederic
    Do Cao, Christine
    Caron, Philippe
    ANNALES D ENDOCRINOLOGIE, 2018, 79 (05) : 569 - 573
  • [48] Widespread potential for growth factor-driven resistance to anti-cancer kinase inhibitors
    Wilson, Timothy R.
    Fridlyand, Jane
    Ribas, Antoni
    Li, Jiang
    Koeppen, Hartmut
    Merchant, Mark
    Neve, Richard
    Settleman, Jeff
    Yan, Yibing
    Penuel, Elicia
    Burton, Luciana
    Chan, Emily
    Peng, Jing
    Lin, Eva
    Wang, Yulei
    Sosman, Jeff
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [49] Development of Tat-fused drug binding protein to improve anti-cancer effect of mammalian target of rapamycin inhibitors
    Lim, Su Yeon
    Kim, Sugyeong
    Kim, Hongbin
    Kim, Hyun-Ouk
    Ha, Suk-Jin
    Lim, Kwang Suk
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2024, 29 (02) : 303 - 312
  • [50] Synthesis and investigation of novel spiro-isoxazolines as anti-cancer agents
    Das, Prasanta
    Omollo, Ann O.
    Sitole, Lungile J.
    McClendon, Eric
    Valente, Edward J.
    Raucher, Drazen
    Walker, Leslie R.
    Hamme, Ashton T., II
    TETRAHEDRON LETTERS, 2015, 56 (14) : 1794 - 1797
12345